400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / MAPK/ERK Pathway / ERK / KO-947
CAS No.: 1695533-89-1
KO-947 is a potent and selective inhibitor of ERK1/2 kinases with potential clinical utility in MAPK pathway dysregulated tumors.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT03051035 | Advanced Malignant Neoplasm | Phase 1 | Recruiting | April 15, 2020 | United States, Minnesota ... more >> Mayo Clinic Not yet recruiting Rochester, Minnesota, United States, 55902 United States, Pennsylvania Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111-2497 Collapse << |
实验方案
技术信息
CAS号 | 1695533-89-1 | 储存条件 |
|
|||||||
分子式 | C21H17N5O | 运输 | 蓝冰 | |||||||
分子量 | 355.39 | 别名 | ||||||||
溶解度 |
|
动物实验配方 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT03051035 | Advanced Malignant Neoplasm | Phase 1 | Recruiting | April 15, 2020 | United States, Minnesota ... more >> Mayo Clinic Not yet recruiting Rochester, Minnesota, United States, 55902 United States, Pennsylvania Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111-2497 Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网